Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染信息库(个性化临床发现资源)相关活动的管理和监管
基本信息
- 批准号:9913351
- 负责人:
- 金额:$ 10.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAcademic Medical CentersAdultAdvisory CommitteesAreaAwardBenignBig DataBiologicalBiologyChildClinicalClinical PathologyCollaborationsCommunicable DiseasesCommunicationCommunitiesCountryDataData AnalysesDevelopmentEducationEducational workshopEnsureEnvironmentEpidemiologistEventFacultyFertilizationFosteringFoundationsFruitGenitourinary System InfectionGenitourinary systemGoalsHealthHeterogeneityHospitalsHuman ResourcesImmersion Investigative TechniqueIndividualInfectionInformaticsInfrastructureInstitutesInternshipsLaboratoriesLeadLeadershipLightLogisticsMedicalMedicineMissionOccupational activity of managing financesOnline SystemsOperating SystemOrganismParentsPathogenesisPathologyPatientsPersonsPilot ProjectsPostdoctoral FellowProcessProductivityRegulationResearchResearch PersonnelResourcesRotationScholarshipScienceSeriesServicesSocietiesSpecialistSpecimenStructureSupervisionTimeUnderrepresented GroupsUnited StatesUnited States National Institutes of HealthUrinary tract infectionUrologyVisionWorkbiobankcareer developmentclinically relevantcollaborative environmentcombatcommunity buildingdata warehousedesignexperienceflexibilityhost-microbe interactionsinnovationlecturesmicrobialmicrobiomemultidisciplinarynovel diagnosticsnovel therapeuticsoperationorganizational structureoutreachpathogenpersonalized medicineprecision medicineprogramsrecruitrepositorysuccesssynergismtoolundergraduate studenturologicweb site
项目摘要
SUMMARY - ADMINISTRATIVE CORE
We propose the Vanderbilt Urologic Infection Repository (VUIR) as a first-in-kind resource for host-pathogen
discovery, one that systematically connects [1] medical data from a vast number of patients who suffer from
urinary tract infections (UTIs) to [2] a biobank of the actual causative organisms. As an informatic and biologic
network, the VUIR will facilitate novel diagnostic and therapeutic strategies to combat UTIs, while providing a
tool to elucidate their underlying pathogenesis. At the same time—given the extensive scope of the VUIR and
its potential for multidisciplinary innovation—the need arises for a strong administrative foundation to coordinate
the program's daily activities and bring to fruition its scientific vision. To these ends, a critical strength of the
VUIR will be its associated Administrative Core (AdCore), a defined personnel structure for organizational
success. The faculty leadership team of the AdCore holds broad expertise in clinical urology (Dr. Douglass
Clayton), microbial pathogenesis (Dr. Maria Hadjifrangiskou), and clinical pathology/laboratory medicine (Dr.
Jonathan Schmitz), further supported by both a Local Executive Committee and External Advisory Committee.
These groups will likewise include strategic representation from informaticians, infectious disease specialists,
hospital epidemiologists, and microbiome experts, providing ongoing thematic direction to the VUIR from the
diverse fields to which the program will contribute. The AdCore will also incorporate dedicated logistical support
from professionals with extensive background in academic and financial administration, as well as web-site
design and event management. In total, this group will ensure that our logistical operations are both proactive
and responsive, coordinating interactions and disseminating specimens/data within and beyond Vanderbilt. The
AdCore will create synergy between the VUIR and complementary institutional structures for precision medicine
and translational discovery, as well as champion pilot projects that build upon VUIR resources. Our ultimate goal,
however, is to create a network of affiliated collaborators across the United States, clinicians and investigators
who could both benefit from and contribute to the combined wealth of data and specimens. Finally, in addition to
supporting scientific innovations, the AdCore will ensure we develop a concomitant footprint in education and
service. Through a combination of workshops, seminars, and immersive experiences, we will connect nationwide
experts in urogenital infection-biology to diverse trainees, from undergraduate students to postdoctoral/clinical
fellows. In addition to content-area education, these interactions will foster networking and career-development
experiences, including opportunities for individuals from underrepresented groups. And reaching beyond
academia, the AdCore will promote outreach to the larger community, building on existing Vanderbilt programs
to educate the public on our scientific mission. In this way, this administrative foundation of the VUIR will
maximize the program's ability to generate discoveries, while disseminating information to broad and varied
audiences.
摘要 - 行政核心
我们建议将范德比尔特泌尿感染存储库 (VUIR) 作为宿主病原体的首个同类资源
一项发现,系统地将来自大量患有以下疾病的患者的医疗数据连接起来 [1]
尿路感染 (UTI) [2] 实际致病微生物的生物库作为信息学和生物学。
VUIR 将促进新的诊断和治疗策略来对抗尿路感染,同时提供
同时考虑到 VUIR 和的广泛范围。
其多学科创新的潜力——需要强大的行政基础来协调
该计划的日常活动并实现其科学愿景是实现这些目标的关键力量。
VUIR 将是其相关的管理核心 (AdCore),这是组织的明确的人员结构
AdCore 的教师领导团队在临床泌尿学领域拥有广泛的专业知识(道格拉斯博士)
Clayton)、微生物发病机制(Maria Hadjifrangiskou 博士)和临床病理学/实验室医学(Dr.
Jonathan Schmitz),并得到当地执行委员会和外部咨询委员会的进一步支持。
这些小组同样将包括来自信息学家、传染病专家、
医院流行病学家和微生物组专家为 VUIR 提供持续的主题指导
AdCore 还将纳入专门的后勤支持。
来自在学术和财务管理以及网站方面具有丰富背景的专业人士
总的来说,该团队将确保我们的后勤运营是积极主动的。
响应、协调互动并在范德比尔特内外传播样本/数据。
AdCore 将在 VUIR 和精准医疗的互补机构结构之间建立协同作用
和转化发现,以及基于 VUIR 资源的冠军试点项目,我们的最终目标,
然而,是要建立一个由遍布美国的附属合作者、人群和调查人员组成的网络
谁可以从数据和样本的综合财富中受益并做出贡献。
支持科学创新,AdCore 将确保我们在教育和
通过研讨会、研讨会和沉浸式体验的结合,我们将连接全国。
泌尿生殖感染生物学专家到不同的受训者,从本科生到博士后/临床
除了内容领域的教育之外,这些互动还将促进网络和职业发展。
经验,包括为来自代表性不足的群体的个人提供机会,并超越他们。
学术界,AdCore 将在现有范德比尔特项目的基础上,促进向更大社区的推广
通过这种方式,VUIR 的行政基金会将向公众宣传我们的科学使命。
最大限度地提高该计划产生发现的能力,同时将信息传播到广泛和多样化的领域
观众。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Hadjifrangiskou其他文献
Maria Hadjifrangiskou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Hadjifrangiskou', 18)}}的其他基金
Targeting cytochrome bd as an anti-biofilm strategy
靶向细胞色素 bd 作为抗生物膜策略
- 批准号:
10642243 - 财政年份:2023
- 资助金额:
$ 10.02万 - 项目类别:
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina
大肠杆菌酸反应机制如何突破阴道定植抗性
- 批准号:
10657442 - 财政年份:2022
- 资助金额:
$ 10.02万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
8816807 - 财政年份:2014
- 资助金额:
$ 10.02万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
9252820 - 财政年份:2014
- 资助金额:
$ 10.02万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
9172228 - 财政年份:2014
- 资助金额:
$ 10.02万 - 项目类别:
Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
与范德比尔特泌尿感染存储库(个性化临床发现资源)相关的活动的管理和监管
- 批准号:
10022301 - 财政年份:
- 资助金额:
$ 10.02万 - 项目类别:
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染存储库,个性化临床发现的资源
- 批准号:
9913352 - 财政年份:
- 资助金额:
$ 10.02万 - 项目类别:
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染存储库,个性化临床发现的资源
- 批准号:
10022306 - 财政年份:
- 资助金额:
$ 10.02万 - 项目类别:
相似海外基金
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
犹他州神经科学临床试验卓越区域网络
- 批准号:
8529637 - 财政年份:2011
- 资助金额:
$ 10.02万 - 项目类别:
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
犹他州神经科学临床试验卓越区域网络
- 批准号:
8709000 - 财政年份:2011
- 资助金额:
$ 10.02万 - 项目类别:
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
犹他州神经科学临床试验卓越区域网络
- 批准号:
8337836 - 财政年份:2011
- 资助金额:
$ 10.02万 - 项目类别:
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
犹他州神经科学临床试验卓越区域网络
- 批准号:
8241308 - 财政年份:2011
- 资助金额:
$ 10.02万 - 项目类别:
Ethical Issues in HIV/AIDS and Substance Abuse Research
艾滋病毒/艾滋病和药物滥用研究中的伦理问题
- 批准号:
7266217 - 财政年份:2005
- 资助金额:
$ 10.02万 - 项目类别: